Table 3.
Area and vein characteristics of 21 DAG first leaves from various genotypes
Genotype | Sample size | Leaf area mm2 |
Leaf vein density mm mm–2 |
Number of secondary veins | Non-meeting secondary veins | Vascular islands |
---|---|---|---|---|---|---|
WT | 134 | 34.3 ± 9.0 | 2.0 ± 0.2 | 7.7 ± 1.0 | 0.7 ± 0.8 | 0 |
fkd1 | 94 | 39.3 ± 14.1a | 1.7 ± 0.2a | 7.1 ± 1.2a | 3.6 ± 1.4a | 1.2 ± 1.0a |
fl1-1 | 23 | 38.3 ± 6.7a | 2.0 ± 0.1b | 7.7 ± 0.6b | 0.2 ± 0.5a,b | 0 |
fl1-2 | 15 | 31.8 ± 10.3 | 1.9 ± 0.2b | 6.8 ± 1.1a | 0.5 ± 0.6b | 0 |
fl2 | 57 | 36.7 ± 11.6 | 1.9 ± 0.4a,b | 7.6 ± 0.7b | 0.7 ± 0.9b | 0 |
fl3 | 97 | 42.5 ± 11.1a | 1.7 ± 0.2a | 7.5 ± 1.0b | 0.2 ± 0.5a,b | 0 |
fkd1/fl1-1 | 27 | 30.3 ± 7.8a,b,c | 1.9 ± 0.1a,b,c | 7.3 ± 1.5 | 4.6 ± 1.5a,b,c | 1.5 ± 1.3a,c |
fkd1/fl1-2 | 24 | 20.1 ± 5.6a,b,c | 2.5 ± 0.3a,b,c | 6.8 ± 0.8a | 3.6 ± 1.4a,c | 2.5 ± 0.9a,b,c |
fkd1/fl2 | 35 | 30.4 ± 6.2a,b,c | 1.9 ± 0.1a,b | 6.4 ± 1.4a,b,c | 3.9 ± 1.2a,c | 2.4 ± 1.4a,b,c |
fkd1/fl3 | 46 | 36.2 ± 9.8c | 1.9 ± 0.1a,b,c | 7.6 ± 0.9b | 4.4 ± 1.1a,b,c | 1.1 ± 0.4a,c |
fkd1/fl2/fl3 | 96 | 25.5 ± 9.4a,b,c,d | 2.0 ± 0.3b,c*,d* | 5.0 ± 1.3a,b,c,d | 2.8 ± 1.1a,b,c,d | 4.9 ± 2.2a,b,c,d |
fkd1/fl1-1/fl2/fl3 | 69 | 17.5 ± 5.7a,b,c,d,e | 2.3 ± 0.30a,b,c,d,e | 3.8 ± 1.2a,b,c,d,e | 1.6 ± 1.1a,b,c,d,e | 3.7 ± 1.3a,b,c,d |
fkd1/fl1-2/fl2/fl3 | 96 | 23.9 ± 6.05a,b,c,d | 2.1 ± 0.2a,b,c,d | 4.2 ± 1.3a,b,c,d,e | 2.07 ± 1.32a,b,c,d,e | 4.7 ± 2.1a,b,c,d |
fl6 | 32 | 29.5 ± 8.5a,b | 1.7 ± 0.2a | 6.3 ± 1.3a,b | 0.4 ± 0.5a,b | 0 |
fl7 | 30 | 27.6 ± 6.2a,b | 2.0 ± 0.3b | 7.3 ± 1.1 | 0.6 ± 0.7b | 0 |
fkd1/fl6/fl7 | 31 | 30.7 ± 6.70a,b | 2.0 ± 0.2b,c* | 6.9 ± 1.4a | 3.09 ± 1.33a,c | 1.7 ± 1.3a,c |
All values are means ±SD. a is significantly different from the wild type (bold), b is significantly different from fkd1 (mutant combinations with fkd1 that are statistically different from fkd1 are underlined), c is significantly different from single mutants, d is different from double mutants, and e is different from the triple mutant. * represents a significant difference from one of the tested double mutants, but not all.